Everything Jason Kelly said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Kelly: AI will outperform humans in biology faster than in English
“And so I feel like these computer brains are going to kick our ass a lot faster in this domain than they do in English.”
Kelly: AI biosecurity lone-actor risk is low due to data scarcity
“The idea that, like, we know how to, like, exactly, like, design for that sort of thing is low. You could try something, but it's not like, oh, I know for sure it's just someone's waiting to do it. Remember, you need data. It's hard to accumulate that. Yeah, i…”
Kelly: Ginkgo gives 10x super-voting shares to all active employees
“At Ginkgo, we took this Silicon Valley idea of founder super voting shares and extended it to the entire employee base. So it's not just us, anyone who's at the company, and it goes away if you leave, ah, gets 10 X voting for their B shares versus the A shares…”
Kelly: Neural Network Analysis Will Function Like Systems Biology
“Like you're about to experience, like the analysis of these neural nets is going to look like systems biology, right? It's going to be like, go in and like, try to back, figure out a thing that you didn't design, my friends.”
Kelly: Major biotech and pharma companies remain fully vertically integrated
“Where's the fast platforms? Like, where's all the horizontal stuff? Where's the operating systems? And it's like nowhere, like vertical integration, Merck, Pfizer, Bayer, Syngenta, like every one of these companies is like its own tech stack top to bottom, you…”
Kelly: Biological AI's main bottleneck is availability of training data
“The big limitation in bio is the availability of data to train these things, right? And so you have this tough situation where, like, everyone is doing these models of training on the same data, right?”
Kelly: Biosecurity should mirror cybersecurity with persistent monitoring and rapid response
“Cybersecurity, I think is a bit the mental model for like what the future of infectious disease response looks like. Persistent monitoring, rapid response, kill it.”
Kelly: Ginkgo operates a 300,000-square-foot robotic data lab
“Yeah, we have a 300,000 square foot robotic lab that they built in the last 10 years, and so we generate that, and we do it in service of our customer projects, we can do our own data generation, but yeah, that's where it comes from.”
Kelly: Ginkgo runs pathogen wastewater monitoring in US, Qatar, and Ukraine
“One of the things we're doing is, like, with the CDC, we run programs where we collect wastewater from inbound airplanes, and we sequence the DNA, and we look for pathogens, we look, we monitor variants and all this, both for flu and COVID, and I can add other…”
NO PRIORSLEDGER